JP2004529172A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004529172A5 JP2004529172A5 JP2002587442A JP2002587442A JP2004529172A5 JP 2004529172 A5 JP2004529172 A5 JP 2004529172A5 JP 2002587442 A JP2002587442 A JP 2002587442A JP 2002587442 A JP2002587442 A JP 2002587442A JP 2004529172 A5 JP2004529172 A5 JP 2004529172A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- salt
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 26
- 150000003839 salts Chemical class 0.000 claims 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 11
- 125000002947 alkylene group Chemical group 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000005236 alkanoylamino group Chemical group 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 125000001589 carboacyl group Chemical group 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR4690A AUPR469001A0 (en) | 2001-05-01 | 2001-05-01 | Cephem compounds |
| AUPR5834A AUPR583401A0 (en) | 2001-06-20 | 2001-06-20 | Cephem compounds |
| PCT/JP2002/004058 WO2002090364A1 (en) | 2001-05-01 | 2002-04-24 | Cephem compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004529172A JP2004529172A (ja) | 2004-09-24 |
| JP2004529172A5 true JP2004529172A5 (enExample) | 2005-12-22 |
| JP4251873B2 JP4251873B2 (ja) | 2009-04-08 |
Family
ID=25646666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002587442A Expired - Fee Related JP4251873B2 (ja) | 2001-05-01 | 2002-04-24 | セフェム化合物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7179801B2 (enExample) |
| EP (1) | EP1392704B1 (enExample) |
| JP (1) | JP4251873B2 (enExample) |
| KR (1) | KR20030090794A (enExample) |
| CN (1) | CN1522259A (enExample) |
| AR (1) | AR033300A1 (enExample) |
| AT (1) | ATE318269T1 (enExample) |
| BR (1) | BR0209452A (enExample) |
| CA (1) | CA2446099A1 (enExample) |
| DE (1) | DE60209341T2 (enExample) |
| ES (1) | ES2254671T3 (enExample) |
| HU (1) | HUP0304042A2 (enExample) |
| MX (1) | MXPA03010002A (enExample) |
| NO (1) | NO20034824L (enExample) |
| NZ (1) | NZ529887A (enExample) |
| PL (1) | PL366507A1 (enExample) |
| RU (1) | RU2003134629A (enExample) |
| TW (1) | TWI224599B (enExample) |
| WO (1) | WO2002090364A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4448821B2 (ja) * | 2002-10-30 | 2010-04-14 | アステラス製薬株式会社 | セフェム化合物 |
| AU2003902380A0 (en) * | 2003-05-16 | 2003-06-05 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| DE602004026451D1 (de) * | 2003-09-18 | 2010-05-20 | Astellas Pharma Inc | Cephem-verbindungen |
| WO2005044819A1 (en) * | 2003-10-28 | 2005-05-19 | Schering Corporation | Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines |
| EP1721906A4 (en) * | 2004-03-05 | 2008-02-27 | Shionogi & Co | METHYLCEPHEM COMPOUND 3-PYRIDINIUM |
| JP2009530228A (ja) * | 2006-03-16 | 2009-08-27 | アステラス製薬株式会社 | セフェム化合物および抗菌薬としての利用 |
| HK1200096A1 (en) | 2011-09-09 | 2015-07-31 | Merck Sharp & Dohme Corp. | Methods for treating intrapulmonary infections |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US20140274994A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Stabilizing ceftolozane |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274993A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane-tazobactam pharmaceutical compositions |
| US10376496B2 (en) | 2013-09-09 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN104140427A (zh) * | 2014-07-05 | 2014-11-12 | 湖南华腾制药有限公司 | 一种四氢吡唑并[1,5-a]嘧啶的制备方法 |
| CN107922435B (zh) * | 2015-09-08 | 2022-05-17 | 桑多斯股份公司 | 由7-氨基头孢烷酸(7-aca)制备头孢洛扎的方法 |
| CN107586305A (zh) * | 2017-06-23 | 2018-01-16 | 浙江惠迪森药业有限公司 | 一种β‑内酰胺类化合物羧基及羟基保护基脱除方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194432A (en) * | 1985-11-22 | 1993-03-16 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| CA1293719C (en) * | 1986-09-22 | 1991-12-31 | Takao Takaya | Cephem compounds and processes for preparation thereof |
| US5210080A (en) * | 1987-09-07 | 1993-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US5663163A (en) * | 1987-09-07 | 1997-09-02 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds and processes for preparation thereof |
| IE63094B1 (en) * | 1987-09-14 | 1995-03-22 | Fujisawa Pharmaceutical Co | Cephem compound and a process for preparation thereof |
| US5173485A (en) * | 1988-03-09 | 1992-12-22 | Fujisawa Pharmaceutical Company, Ltd. | Cephem compounds |
| GB8905301D0 (en) * | 1989-03-08 | 1989-04-19 | Fujisawa Pharmaceutical Co | New cephem compound and a process for preparation thereof |
| US5215982A (en) * | 1989-11-10 | 1993-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| KR910015587A (ko) * | 1990-02-27 | 1991-09-30 | 후지사와 토모키치로 | 세펨 화합물 |
| JPH09110877A (ja) | 1995-10-17 | 1997-04-28 | Katayama Seiyakushiyo:Kk | セフェム化合物、その製造法及びそれを含有する抗菌剤 |
| AUPN955596A0 (en) * | 1996-04-30 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| JP4448821B2 (ja) * | 2002-10-30 | 2010-04-14 | アステラス製薬株式会社 | セフェム化合物 |
| AU2003902380A0 (en) * | 2003-05-16 | 2003-06-05 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| DE602004026451D1 (de) * | 2003-09-18 | 2010-05-20 | Astellas Pharma Inc | Cephem-verbindungen |
-
2002
- 2002-04-24 MX MXPA03010002A patent/MXPA03010002A/es unknown
- 2002-04-24 BR BR0209452-5A patent/BR0209452A/pt not_active Application Discontinuation
- 2002-04-24 DE DE60209341T patent/DE60209341T2/de not_active Expired - Lifetime
- 2002-04-24 JP JP2002587442A patent/JP4251873B2/ja not_active Expired - Fee Related
- 2002-04-24 CN CNA028131703A patent/CN1522259A/zh active Pending
- 2002-04-24 HU HU0304042A patent/HUP0304042A2/hu unknown
- 2002-04-24 US US10/475,845 patent/US7179801B2/en not_active Expired - Fee Related
- 2002-04-24 CA CA002446099A patent/CA2446099A1/en not_active Abandoned
- 2002-04-24 NZ NZ529887A patent/NZ529887A/en unknown
- 2002-04-24 PL PL02366507A patent/PL366507A1/xx unknown
- 2002-04-24 KR KR10-2003-7014145A patent/KR20030090794A/ko not_active Withdrawn
- 2002-04-24 RU RU2003134629/04A patent/RU2003134629A/ru not_active Application Discontinuation
- 2002-04-24 EP EP02722730A patent/EP1392704B1/en not_active Expired - Lifetime
- 2002-04-24 AT AT02722730T patent/ATE318269T1/de not_active IP Right Cessation
- 2002-04-24 WO PCT/JP2002/004058 patent/WO2002090364A1/en not_active Ceased
- 2002-04-24 ES ES02722730T patent/ES2254671T3/es not_active Expired - Lifetime
- 2002-04-29 TW TW091108864A patent/TWI224599B/zh not_active IP Right Cessation
- 2002-04-30 AR ARP020101603A patent/AR033300A1/es unknown
-
2003
- 2003-10-29 NO NO20034824A patent/NO20034824L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004529172A5 (enExample) | ||
| ES2540810T3 (es) | Proceso para preparar compuestos azabicíclicos | |
| CA2504730A1 (en) | Cephem compounds | |
| JP2008255122A5 (enExample) | ||
| JP2008512490A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2006509749A5 (enExample) | ||
| EP2379540A1 (de) | Dipeptoid-prodrugs und ihre verwendung | |
| RU2003134629A (ru) | Соединения цефема | |
| KR880003958A (ko) | 신규 세펨화합물 및 그의 제조방법 | |
| KR970701719A (ko) | 헤테로고리화합물과 그것의 제법 및 사용(heterocyclic compounds, their preparation and use) | |
| RU2011133128A (ru) | Противоопухолевые соединения дигидропиран-2-она | |
| JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
| RU2002123641A (ru) | С-4 карбонатсодержащие таксаны | |
| JP2004531478A5 (enExample) | ||
| JP5602731B2 (ja) | アーテミシニンの二量体誘導体および抗ガン療法における用途 | |
| EP1661882B1 (en) | Compound having anti-HCV activity and process for producing the same | |
| JP2012532894A5 (enExample) | ||
| TWI385172B (zh) | 新穎化合物 | |
| RU2007138582A (ru) | Пероральные дозированные формы производных гемцитабина | |
| JP2009513562A5 (enExample) | ||
| JP2001515895A5 (enExample) | ||
| JP2009536188A5 (enExample) | ||
| JP2006096734A5 (enExample) | ||
| US6310058B1 (en) | Antimycobacterial agents |